RBC Capital Starts OptimizeRX (OPRX) at Outperform, 'Optimizing Drug Marketing at the Point of Care'
Tweet Send to a Friend
RBC Capital analyst Sean Dodge initiates coverage on OptimizeRX (NASDAQ: OPRX) with a Outperform rating and a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
